Amedisys Operating Income 2010-2024 | AMED

Amedisys operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Amedisys Annual Operating Income
(Millions of US $)
2023 $156
2022 $181
2021 $252
2020 $219
2019 $177
2018 $155
2017 $79
2016 $57
2015 $-9
2014 $24
2013 $-155
2012 $-109
2011 $-469
2010 $211
2009 $238
Amedisys Quarterly Operating Income
(Millions of US $)
2024-09-30 $30
2024-06-30 $52
2024-03-31 $32
2023-12-31 $34
2023-09-30 $42
2023-06-30 $38
2023-03-31 $42
2022-12-31 $46
2022-09-30 $39
2022-06-30 $48
2022-03-31 $48
2021-12-31 $48
2021-09-30 $57
2021-06-30 $78
2021-03-31 $69
2020-12-31 $62
2020-09-30 $63
2020-06-30 $50
2020-03-31 $44
2019-12-31 $42
2019-09-30 $47
2019-06-30 $45
2019-03-31 $44
2018-12-31 $36
2018-09-30 $40
2018-06-30 $43
2018-03-31 $36
2017-12-31 $30
2017-09-30 $23
2017-06-30 $0
2017-03-31 $25
2016-12-31 $14
2016-09-30 $14
2016-06-30 $18
2016-03-31 $11
2015-12-31 $17
2015-09-30 $17
2015-06-30 $16
2015-03-31 $-58
2014-12-31 $15
2014-09-30 $16
2014-06-30 $13
2014-03-31 $-20
2013-12-31 $-10
2013-09-30 $-154
2013-06-30 $4
2013-03-31 $5
2012-12-31 $-152
2012-09-30 $15
2012-06-30 $15
2012-03-31 $12
2011-12-31 $16
2011-09-30 $-555
2011-06-30 $40
2011-03-31 $30
2010-12-31 $56
2010-09-30 $37
2010-06-30 $56
2010-03-31 $62
2009-12-31 $71
2009-09-30 $61
2009-06-30 $60
2009-03-31 $47
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.948B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00